Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine
December 04, 2019
December 04, 2019
PLYMOUTH MEETING, Pennsylvania, Dec. 4 -- The National Comprehensive Cancer Network issued the following news release:
* * *
- Newly updated and expanded NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic clarify who should be tested for cancer-causing genetic mutations.
- Experts caution about risks of direct-to-consumer genetic testing and stress the importance of genetic counseling.
* * *
. . .
* * *
- Newly updated and expanded NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic clarify who should be tested for cancer-causing genetic mutations.
- Experts caution about risks of direct-to-consumer genetic testing and stress the importance of genetic counseling.
* * *
. . .